Leidos said Monday it won 5-year $900 million product research and development contract with the U.S. Army Medical Research and Materiel Command.
Leidos, based in Reston, Va., is a science and technology solutions company that works mainly in in national security, health and engineering.
Under the indefinite delivery and indefinite quantity contract, Leidos will support the U.S. Defense departments, including the USARMC, Joint Project Manager Medical Countermeasure Systems and other Department of Defense entities, the company said.
“Our life sciences team located in Frederick, Maryland, led by Dr. Jim Pannucci, has proudly supported the U.S. Army Medical Research and Material Command for more than 33 years. Our distinguished scientists and researchers look forward to providing research and development for medical products to deliver solutions that can help save and improve the lives of our military service members,” Leidos federal health deputy group prez Jerry Hogge said in a press release.
Leidos is 1 of 4 companies eligible for such contract work with the DoD.
The contract work includes supporting the development of new drugs, vaccines, blood products, medical devics and medical support equipment that “enhances readiness, ensures the provision of the highest quality medical and preventive care to the DoD, and maximizes survival of medical casualties on the battlefield,” according to the company.